Alpha Cognition Inc. (ACOG) ROE
- 2026-06-30: ROE -44.26%.
- 2026-03-31: ROE -48.47%.
- 2025-12-31: ROE -36.94%.
- 2025-09-30: ROE -65.03%.
Complete source-backed roe history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|---|
| 2026-06-30 | -44.26% |
| 2026-03-31 | -48.47% |
| 2025-12-31 | -36.94% |
| 2025-09-30 | -65.03% |
| 2025-06-30 | -84.57% |
| 2025-03-31 | -29.90% |
| 2024-12-31 | -37.83% |
| 2024-09-30 | 572.57% |
| 2024-06-30 | -1545.27% |
| 2024-03-31 | -3143.56% |
Annual ROE
| Date | ROE |
|---|---|
| 2025-12-31 | -33.06% |
| 2024-12-31 | -37.83% |
| 2023-12-31 | 292.61% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |